Staff Reporter :
The High Court on Tuesday order 20 pharmaceuticals to stop manufacturing of medicines within seven days for their failure to maintain drug standard.
The bench comprising Justice Syed Muhammad Dastagir Husain and Justice A K M Shahidul Hossain passed the order after hearing on a petition.
The 20 pharmaceutical companies are, Axim Pharmaceuticals, Avert, Bikalpo, Dolphin, Drugland, Globe Laboratories, Jalpha, Kafma, Medico, National Drug, North Bengal, Remo Chemicals, Rid Pharma, Skylab, Spark, Star, Shunipun, Today, Tropical and Universal Pharmaceuticals.
The court issued the rule asking the authorities concerned to explain as to why the licenses of the companies should not be declared illegal.
It has also ordered 14 other companies to stop manufacturing of antibiotics within the same period.
The 14 companies are Ad Din, Alkad, Belsen, Bengal Drug, Bristol, Crystal, Indo-Bangla, Millat, MST Pharma, Orbit, Pharmic, Phoenix, Rasha and Save Pharmaceuticals.
Health Secretary, Director General and Director of Health Directorate, Director General of Consumer Rights Directorate and Director of Drug Administration have been asked to ensure stoppage of production of life saving drugs by 20 pharmaceutical companies within seven days and to submit compliance report to the court within two weeks. The court has also directed the Inspector General of Police and Director General of RAB to cooperate in this regard.
The Health Secretary, the Director General (DG) of the Health Services, the Director of the Drug Administration, the Inspector General of Police, The Director General of National Consumer Rights Protection Department and Rapid Action Battalion (RAB) have been asked to respond to the rule within four weeks.
Advocate Manzil Murshid filed the writ on behalf of Human Rights and Peace for Bangladesh following a report published in a national English daily on April 19 this year.
The court’s order was given yesterday after initial hearing on the petition, which sought an order to cancel licenses of these drug-producing companies.
The High Court on Tuesday order 20 pharmaceuticals to stop manufacturing of medicines within seven days for their failure to maintain drug standard.
The bench comprising Justice Syed Muhammad Dastagir Husain and Justice A K M Shahidul Hossain passed the order after hearing on a petition.
The 20 pharmaceutical companies are, Axim Pharmaceuticals, Avert, Bikalpo, Dolphin, Drugland, Globe Laboratories, Jalpha, Kafma, Medico, National Drug, North Bengal, Remo Chemicals, Rid Pharma, Skylab, Spark, Star, Shunipun, Today, Tropical and Universal Pharmaceuticals.
The court issued the rule asking the authorities concerned to explain as to why the licenses of the companies should not be declared illegal.
It has also ordered 14 other companies to stop manufacturing of antibiotics within the same period.
The 14 companies are Ad Din, Alkad, Belsen, Bengal Drug, Bristol, Crystal, Indo-Bangla, Millat, MST Pharma, Orbit, Pharmic, Phoenix, Rasha and Save Pharmaceuticals.
Health Secretary, Director General and Director of Health Directorate, Director General of Consumer Rights Directorate and Director of Drug Administration have been asked to ensure stoppage of production of life saving drugs by 20 pharmaceutical companies within seven days and to submit compliance report to the court within two weeks. The court has also directed the Inspector General of Police and Director General of RAB to cooperate in this regard.
The Health Secretary, the Director General (DG) of the Health Services, the Director of the Drug Administration, the Inspector General of Police, The Director General of National Consumer Rights Protection Department and Rapid Action Battalion (RAB) have been asked to respond to the rule within four weeks.
Advocate Manzil Murshid filed the writ on behalf of Human Rights and Peace for Bangladesh following a report published in a national English daily on April 19 this year.
The court’s order was given yesterday after initial hearing on the petition, which sought an order to cancel licenses of these drug-producing companies.
